BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
| | | | | |

BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS

On Dec. 18, 2024, BiVACOR, a clinical-stage medical device company, announced the successful completion of the first phase…

Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species resistant to Albendazole/Ivermectin Combination Treatment
| | | | | | |

Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species resistant to Albendazole/Ivermectin Combination Treatment

On Dec. 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported a study with patient…